Skip to Main Content

Paper Details

Characteristics of patients with chronic kidney disease and Type 2 diabetes initiating finerenone in the USA: a multi-database, cross-sectional study.
J Comp Eff Res
1
2023
CKD, CKD-T2D, Finerenone, SGLT2i, T2D, Type 2 diabetes, albumin, chronic kidney disease, creatinine, finerenone, glucose, patients, renin, sodium-, sodium-glucose, sodium-glucose cotransporter 2
Author NameAffiliation
David VizcayaIntegrated Evidence Generation. Bayer Pharmaceuticals
David VizcayaIntegrated Evidence Generation. Bayer Pharmaceuticals
  • 1 - 2

Datasets

Release 1.2